Multi-Cancer Early Detection: Framing the Future of Cancer Screening

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Multi-Cancer Early Detection: Framing the Future of Cancer Screening



ReachMD Healthcare Image

Are new cancer screening tools around the corner to complement the existing standards of care? And how could we detect more cancers earlier?

  • Sponsored by

  • Overview

    Can multi-cancer early detection (MCED) tests potentially lead to a reduction in the number of people who die from the disease by improving screening rates and extending screening for cancers without standard screening today?  So what do we need to know about these tests? To discuss this more in-depth, Dr. Charles Turck is joined by Dr. Tomasz Beer, Chief Medical Officer for Multi-Cancer Early Detection at Exact Sciences Corporation and Adjunct Professor of Medicine at the OHSU Knight Cancer Institute.


    © 2022 Exact Sciences Corporation. All rights reserved.
    US.CAG.00020.HCP 12/22

  • Disclaimer

    This presentation contains information for a technology under development and has not been cleared or approved by the Food and Drug Administration or any other national regulatory authority. The features describe current development goals, and claims have yet to be established.

Schedule30 Sep 2023